Hexarelin, a synthetic hexapeptide, has garnered attention in various research domains due to its intriguing biochemical ...

Tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analog, has garnered significant attention in scientific ...

Amylin is an attractive target in the management of obesity, since it is a peptide hormone co-secreted with insulin in response to food intake, and suppresses appetite and delays gastric emptying. At ...

A new study from Imperial has shown that the physical structure of food influences the hormones released as part of digestion ...

I had the conversation I'd been preparing for over four years. Jay Campbell, author of The Testosterone Optimization Bible ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

GLP-1 inhibits glucagon release, which is a hormone that raises blood sugar levels. GLP-1 prolongs gastric emptying and leads ...

C-Peptide Increases in Insulin-Deficient Subgroups: Patients with insulin deficient diabetes (n=45) ... Beta cells are found in the pancreas and are responsible for the synthesis and secretion of ...

Insulin itself is a peptide hormone, and newer peptide analogs have transformed diabetes management. Beyond insulin , glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized ...

The C-peptide test is a way of estimating how much of the hormone insulin your body creates. This test can help doctors determine what type of diabetes you have. It can also help show how far your ...

Diabetes, Hormone Disorder Drugs Could Be Derived from Deadly Sea Snail Toxin August 20, 2024 ...